These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8816817)

  • 1. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD.
    McKenna TS; Lubroth J; Rieder E; Baxt B; Mason PW
    J Virol; 1995 Sep; 69(9):5787-90. PubMed ID: 7637023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context.
    Gutiérrez-Rivas M; Pulido MR; Baranowski E; Sobrino F; Sáiz M
    J Gen Virol; 2008 Oct; 89(Pt 10):2531-2539. PubMed ID: 18796722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor.
    Bai X; Bao H; Li P; Wei W; Zhang M; Sun P; Cao Y; Lu Z; Fu Y; Xie B; Chen Y; Li D; Luo J; Liu Z
    Virol J; 2014 Jul; 11():132. PubMed ID: 25056022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors.
    Villaverde A; Feliu JX; Harbottle RP; Benito A; Coutelle C
    Gene; 1996 Nov; 180(1-2):101-6. PubMed ID: 8973352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle.
    Rieder E; Henry T; Duque H; Baxt B
    J Virol; 2005 Oct; 79(20):12989-98. PubMed ID: 16189001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.
    Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B
    J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
    Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
    Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.
    Ward G; Rieder E; Mason PW
    J Virol; 1997 Oct; 71(10):7442-7. PubMed ID: 9311823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.
    Jackson T; Sheppard D; Denyer M; Blakemore W; King AM
    J Virol; 2000 Jun; 74(11):4949-56. PubMed ID: 10799568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.
    Neff S; Sá-Carvalho D; Rieder E; Mason PW; Blystone SD; Brown EJ; Baxt B
    J Virol; 1998 May; 72(5):3587-94. PubMed ID: 9557639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of soluble integrin resistant mutants of foot-and-mouth disease virus.
    Lawrence P; LaRocco M; Baxt B; Rieder E
    Virol J; 2013 Jan; 10():2. PubMed ID: 23282061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication.
    Piccone ME; Rieder E; Mason PW; Grubman MJ
    J Virol; 1995 Sep; 69(9):5376-82. PubMed ID: 7636982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
    Liebermann H; Dölling R; Schmidt D; Thalmann G
    Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.